The Spiration® Valve System (SVS) Post-Market Registry Study for Severe Emphysema
Status: Recruiting
Location: See all (13) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult patients with shortness of breath and hyperinflation associated with severe emphysema and evidence of low collateral ventilation.
• Subjects must understand and voluntarily sign an informed consent form.
Locations
United States
Arizona
Dignity Health St. Joseph's Hospital and Medical Center
RECRUITING
Phoenix
California
El Camino, Taft Center for Clinical Research
RECRUITING
Mountain View
Illinois
Northwestern University, Division of Pulmonary and Critical Care Medicine
RECRUITING
Chicago
University of Chicago
RECRUITING
Chicago
Louisiana
LSU Health Shreveport
RECRUITING
Shreveport
Massachusetts
Beth Israel Decaconess
RECRUITING
Boston
Mississippi
Memorial Hospital at Gulfport
RECRUITING
Gulfport
North Carolina
Duke University Medical Center
RECRUITING
Durham
Pennsylvania
Penn State Milton S. Hershey Medical Center
RECRUITING
Hershey
Temple University
RECRUITING
Philadelphia
South Carolina
AnMed Health
RECRUITING
Anderson
Texas
Baylor Scott & White Research Institute
RECRUITING
Dallas
University of Texas Southwestern
RECRUITING
Dallas
Contact Information
Primary
Adorn Nelson
adorn.nelson@olympus.com
(281) 221-6665
Time Frame
Start Date: 2021-10-09
Estimated Completion Date: 2028-04
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Olympus Corporation of the Americas